Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Treprostinil for Digital Ulcers in Scleroderma Extension
NCT00848107Phase 2Terminated
- Sponsor
- United Therapeutics Corporation
- Start
- Sep 2009
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of treprostinil in systemic sclerosis (SSc), Digital ulcer, sponsored by United Therapeutics Corporation. Started Sep 2009; status: terminated.
02
Drugs
treprostinil
03
Conditions
systemic sclerosis (SSc)Digital ulcer
Beyond the preview
Go deeper on NCT00848107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848107.